https://biotechmorning.com/news/anthropic-claude-banned-federal-healthcare Biotech Morning en 2026-04-08T14:10:16.812Z The Safest AI in Tech Just Got Banned From U.S. Healthcare https://biotechmorning.com/news/biogen-alloy-anticlastic-aso-partnership Biotech Morning en 2026-04-08T14:09:39.953Z Biogen's Bet on a Twisted Piece of Chemistry https://biotechmorning.com/news/sidewinder-therapeutics-137m-series-b-adc Biotech Morning en 2026-04-08T14:08:55.017Z $137 Million for a Cancer Drug That Doesn't Exist Yet https://biotechmorning.com/news/jeito-capital-1-2-billion-european-biopharma-fund Biotech Morning en 2026-04-08T14:08:08.348Z Europe's Biggest Bet on Itself Just Got a $1.2 Billion Price Tag https://biotechmorning.com/news/triglyceride-aneurysm-causal-link-first-drug-lead Biotech Morning en 2026-04-08T14:07:25.809Z The Condition With Zero Drugs Just Found Its First Lead https://biotechmorning.com/news/anthropic-coefficient-bio-acquisition Biotech Morning en 2026-04-07T14:15:33.206Z Anthropic Just Paid $400M for a Startup With No Product https://biotechmorning.com/news/neurocrine-soleno-prader-willi-acquisition Biotech Morning en 2026-04-07T14:14:52.384Z Neurocrine Just Bet $2.9 Billion on an Unstoppable Appetite https://biotechmorning.com/news/gilead-tubulis-adc-acquisition-3-billion Biotech Morning en 2026-04-07T14:14:09.859Z Gilead Just Dropped $3.15 Billion on a Munich Startup You've Never Heard Of https://biotechmorning.com/news/replimune-rp1-fda-identity-crisis Biotech Morning en 2026-04-07T14:13:22.851Z The Cancer Drug Caught in the FDA's Identity Crisis https://biotechmorning.com/news/biogen-alloy-aso-delivery-deal Biotech Morning en 2026-04-07T14:12:37.387Z Biogen's Billion-Dollar Problem Has a Tiny, Twisted Solution https://biotechmorning.com/news/ai-designed-opioid-addiction-drug Biotech Morning en 2026-04-07T14:11:55.022Z An AI Just Designed an Opioid Addiction Drug. No Human Chemist Required. https://biotechmorning.com/news/sanofi-lunsekimig-mixed-phase-2-results Biotech Morning en 2026-04-07T14:11:10.459Z Sanofi's Two-for-One Drug Just Went One-for-Two https://biotechmorning.com/news/takeda-ghosted-denali-brain-drug-deal Biotech Morning en 2026-04-07T14:10:24.214Z Takeda Just Ghosted Denali on a $150M Brain Drug Deal https://biotechmorning.com/news/fda-ghosted-kezar-life-sciences Biotech Morning en 2026-04-07T14:09:41.460Z The FDA Ghosted a Biotech Company. It Didn't Survive.